2094 related articles for article (PubMed ID: 18926148)
41. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).
Steg PG; Dabbous OH; Feldman LJ; Cohen-Solal A; Aumont MC; López-Sendón J; Budaj A; Goldberg RJ; Klein W; Anderson FA;
Circulation; 2004 Feb; 109(4):494-9. PubMed ID: 14744970
[TBL] [Abstract][Full Text] [Related]
42. Predictors of short term mortality in heart failure - insights from the Euro Heart Failure survey.
Velavan P; Khan NK; Goode K; Rigby AS; Loh PH; Komajda M; Follath F; Swedberg K; Madeira H; Cleland JG
Int J Cardiol; 2010 Jan; 138(1):63-9. PubMed ID: 18789548
[TBL] [Abstract][Full Text] [Related]
43. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
44. Association between performance measures and clinical outcomes for patients hospitalized with heart failure.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Pieper K; Sun JL; Yancy C; Young JB;
JAMA; 2007 Jan; 297(1):61-70. PubMed ID: 17200476
[TBL] [Abstract][Full Text] [Related]
45. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
[TBL] [Abstract][Full Text] [Related]
46. Long-term survival after heart failure: a contemporary population-based perspective.
Goldberg RJ; Ciampa J; Lessard D; Meyer TE; Spencer FA
Arch Intern Med; 2007 Mar; 167(5):490-6. PubMed ID: 17353497
[TBL] [Abstract][Full Text] [Related]
47. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology and risk stratification in acute heart failure.
Fonarow GC
Am Heart J; 2008 Feb; 155(2):200-7. PubMed ID: 18215587
[TBL] [Abstract][Full Text] [Related]
49. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
[TBL] [Abstract][Full Text] [Related]
50. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
[TBL] [Abstract][Full Text] [Related]
51. beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality.
Abbott KC; Trespalacios FC; Agodoa LY; Taylor AJ; Bakris GL
Arch Intern Med; 2004 Dec 13-27; 164(22):2465-71. PubMed ID: 15596637
[TBL] [Abstract][Full Text] [Related]
52. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Am Coll Cardiol; 2008 Jul; 52(3):190-9. PubMed ID: 18617067
[TBL] [Abstract][Full Text] [Related]
53. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.
Blair JE; Khan S; Konstam MA; Swedberg K; Zannad F; Burnett JC; Grinfeld L; Maggioni AP; Udelson JE; Zimmer CA; Ouyang J; Chen CF; Gheorghiade M;
Eur Heart J; 2009 Jul; 30(13):1666-73. PubMed ID: 19411662
[TBL] [Abstract][Full Text] [Related]
54. Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year.
Biegus J; Zymliński R; Szachniewicz J; Siwołowski P; Pawluś A; Banasiak W; Jankowska EA; Ponikowski P
Kardiol Pol; 2011; 69(10):997-1005. PubMed ID: 22006596
[TBL] [Abstract][Full Text] [Related]
55. Statins and mortality among elderly patients hospitalized with heart failure.
Foody JM; Shah R; Galusha D; Masoudi FA; Havranek EP; Krumholz HM
Circulation; 2006 Feb; 113(8):1086-92. PubMed ID: 16490817
[TBL] [Abstract][Full Text] [Related]
56. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
57. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
[TBL] [Abstract][Full Text] [Related]
58. [Heart failure: critical patients].
Fabbri G; Gorini M; Maggioni AP; Oliva F;
G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
[TBL] [Abstract][Full Text] [Related]
59. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
Fonarow GC; Gheorghiade M; Abraham WT
Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
[TBL] [Abstract][Full Text] [Related]
60. Mortality benefit of a comprehensive heart failure disease management program in indigent patients.
Hebert KA; Horswell RL; Dy S; Key IJ; Butler MK; Cerise FP; Arcement LM
Am Heart J; 2006 Feb; 151(2):478-83. PubMed ID: 16442918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
